Investigation of Metabolic Bone Diseases, Molecular Cellular and Genetic Determinants of Bone Structure and Formation, Integrative Physiology of the Skeleton
Therapy of Osteoporosis with Calcium and Vitamin D
Bess Dawson-Hughes, M.D., Tufts University School of Medicine, Boston, Massachusetts, USA
NIH Women’s Health Initiative
Rebecca Jackson, M.D., Ohio State University, Columbus, Ohio, USA
Vitamin D Toxicity, Policy, and Science
Reinhold Vieth, Ph.D., Mount Sinai Hospital, Toronto, Ontario, Canada
Establishing Guidelines for Vitamin D Intake
Elizabeth A. Yetley, Ph.D., Office of Dietary Supplements, National Institute of Health, Bethesda, Maryland, USA
Supported by educational grants from Eli Lilly and Company, Merck & Co., Inc., NPS Pharmaceuticals, The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and sanofi-aventis, US) and Immunodiagnostic Systems.
Funding for this conference was made possible (in part) by Grant AR055036 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases and the Office of Dietary Supplements. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Length: 110 minutes